CRITICAL LIMB ISCHEMIA CLINICAL RESEARCH & EDUCATION (EIN 825450543) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

CARMEN HEANEY

Phone

6169707385

Tax Period

2024-01-01 to 2024-12-31

CRITICAL LIMB ISCHEMIA CLINICAL RESEARCH & EDUCATION, founded in 2018, is a micro nonprofit that reported $7K in total revenue in fiscal year 2024. Revenue fell 95% from the prior year — a significant decline worth monitoring. Expenses of $96K exceeded revenue, resulting in a 1230% operating deficit.

Mission

THE PRIMARY ACTIVITY OF THE ORGANIZATION IS TO UNDERTAKE CLINICAL RESEARCH OF NEWLY DEVELOPED DEVICES AND PROCEDURES IN THE AREA OF PERIPHERAL VASCULAR DISEASE AND CARDIOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $7,245

Investment Income $0

Other Revenue $0

TOTAL REVENUE $7,245

Expense Breakdown

Grants Paid $50,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $86,007

Other Expenses $46,333

TOTAL EXPENSES $96,333

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,245	$142,807	-0.9%
Expenses	$96,333	$166,819	-0.4%
Net Income	$-89,088	$-24,012	+2.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$18,224

Total Directors

$23,724

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CARMEN HEANEY	PRESIDENT	10.25	Officer Director	$12,000	$0	$12,000
BETHANY STANISIEWSKI	SECRETARY/TREASURER	8.25	Officer Director	$6,224	$0	$6,224
JANELLE EVANS	DIRECTOR	2.25	Director	$5,500	$0	$5,500

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,245	$96,333	No data	$-89,088
2023	$142,807	$166,819	$89,088	$-24,012
2022	$80,575	$131,901	$113,100	$-51,326
2021	$167,946	$71,807	$164,426	$96,139
2020	$120,103	$133,434	$68,287	$-13,331
2019	$111,243	$114,233	$81,618	$-2,990

CRITICAL LIMB ISCHEMIA CLINICAL RESEARCH & EDUCATION